Welcome to PCR London Valves 2016: back to the UK

The field of transcatheter therapies for valvular heart disease is a never-ending source of technical and device innovation, novel indications and new treatment solutions. The interest of the scientific community in this sub-discipline of interventional cardiology is demonstrated by the extraordinary volume of literature on the field, as well as the variety of national and international meetings, symposia and teaching courses focusing on this topic. The annual PCR London Valves meeting – this year back to its original venue– represents the world’s largest course specifically addressing the rapidly expanding and innovative field of transcatheter therapies for valvular heart disease. The ...